Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term hepatitis B antibody persistence and Engerix-B Kinder challenge study in previously Infanrix hexa-vaccinated children
2010-022538-10Phase 4Completed
- Sponsor
- GSK
- Start
- Jan 2011
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by GSK. Primary endpoints: Anti-HBs antibody response after challenge dose, Persistence of anti-HBs antibodies and 1 more. Started Jan 2011; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2010-022538-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022538-10.